Detalhe da pesquisa
1.
Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747).
BJU Int
; 119(4): 522-529, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27256016
2.
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Nat Med
; 29(7): 1760-1774, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414897
3.
Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer.
BJUI Compass
; 3(6): 484-493, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36267204
4.
Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study.
Eur Urol
; 80(1): 12-15, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33653635
5.
Development and validation of a follow-up methodology for a randomised controlled trial, utilising routine clinical data as an alternative to traditional designs: a pilot study to assess the feasibility of use for the BladderPath trial.
Pilot Feasibility Stud
; 6(1): 165, 2020 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33292682
6.
Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial.
Eur Urol
; 75(1): 63-71, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30274699
7.
Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical Trial.
JAMA Oncol
; 2(4): 493-9, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26794729
8.
TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer.
Health Technol Assess
; 20(53): 1-288, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27434595